Both in Pharmaceuticals
InMed Pharmaceuticals vs Connect Biopharma Holdings Limited
Over the past year INM returned +405.8% and CNTB returned −53.5%; their daily moves had a correlation of -0.02.
INM +405.8% CNTB −53.5%Growth of $1, one year, split-adjusted
| Metric | INM | CNTB |
|---|---|---|
| Price | $8.75 | $0.7805 |
| Market cap | $48.1M | $49.2M |
| Today | +420.83% | +0.83% |
| 1 month | +557.9% | −13.8% |
| 6 months | +1104.6% | −68.5% |
| Year to date | +725.5% | −72.3% |
| 1 year | +373.0% | −52.7% |
| Revenue growth (YoY) | — | +5666.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −624.4% |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | 16.6× |
| Net cash | $2.2M | $31.5M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 137.4% |
| Short % of float | 0.1% | 18.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).